These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 22784133)

  • 21. Update on the treatment of diabetic retinopathy.
    Yam JC; Kwok AK
    Hong Kong Med J; 2007 Feb; 13(1):46-60. PubMed ID: 17277392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. From pathobiology to the targeting of pericytes for the treatment of diabetic retinopathy.
    Arboleda-Velasquez JF; Valdez CN; Marko CK; D'Amore PA
    Curr Diab Rep; 2015 Feb; 15(2):573. PubMed ID: 25620405
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Better outcomes for patients with diabetic macular edema.
    Schachat AP
    Ophthalmology; 2011 Apr; 118(4):607-8. PubMed ID: 21459213
    [No Abstract]   [Full Text] [Related]  

  • 24. New insights into the pathophysiology of diabetic retinopathy: potential cell-specific therapeutic targets.
    Gardner TW; Antonetti DA; Barber AJ; LaNoue KF; Nakamura M
    Diabetes Technol Ther; 2000; 2(4):601-8. PubMed ID: 11469624
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Canadian Ophthalmological Society Evidence-based Clinical Practice Guidelines for the Management of Diabetic Retinopathy - executive summary.
    ; Hooper P; Boucher MC; Cruess A; Dawson KG; Delpero W; Greve M; Kozousek V; Lam WC; Maberley DA
    Can J Ophthalmol; 2012 Apr; 47(2):91-6. PubMed ID: 22560411
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatments for Diabetic Macular Edema: Past, Present, and Future.
    Jansen ME; Hariprasad SM; Singer MA
    Ophthalmic Surg Lasers Imaging Retina; 2016 Sep; 47(9):794-800. PubMed ID: 27631474
    [No Abstract]   [Full Text] [Related]  

  • 27. DIABETIC MACULAR EDEMA.
    Musat O; Cernat C; Labib M; Gheorghe A; Toma O; Zamfir M; Boureanu AM
    Rom J Ophthalmol; 2015; 59(3):133-6. PubMed ID: 26978879
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diabetic retinopathy.
    Bloomgarden ZT
    Diabetes Care; 2008 May; 31(5):1080-3. PubMed ID: 18445731
    [No Abstract]   [Full Text] [Related]  

  • 29. Neurodegeneration in the diabetic eye: new insights and therapeutic perspectives.
    Simó R; Hernández C;
    Trends Endocrinol Metab; 2014 Jan; 25(1):23-33. PubMed ID: 24183659
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interim Safety Data Comparing Ranibizumab With Panretinal Photocoagulation Among Participants With Proliferative Diabetic Retinopathy.
    Gross JG; Glassman AR; Klein MJ; Jampol LM; Ferris FL; Bressler NM; Beck RW
    JAMA Ophthalmol; 2017 Jun; 135(6):672-673. PubMed ID: 28492921
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vascular endothelial growth factor and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives.
    Caldwell RB; Bartoli M; Behzadian MA; El-Remessy AE; Al-Shabrawey M; Platt DH; Caldwell RW
    Diabetes Metab Res Rev; 2003; 19(6):442-55. PubMed ID: 14648803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Eyes on the prize. Prevention is crucial in combating retinopathy.
    Gebel E
    Diabetes Forecast; 2010 Sep; 63(9):32, 35. PubMed ID: 20839603
    [No Abstract]   [Full Text] [Related]  

  • 33. Upregulation of retinal vascular endothelial growth factor mRNAs in spontaneously diabetic rats without ophthalmoscopic retinopathy. A possible participation of advanced glycation end products in the development of the early phase of diabetic retinopathy.
    Segawa Y; Shirao Y; Yamagishi S; Higashide T; Kobayashi M; Katsuno K; Iyobe A; Harada H; Sato F; Miyata H; Asai H; Nishimura A; Takahira M; Souno T; Segawa Y; Maeda K; Shima K; Mizuno A; Yamamoto H; Kawasaki K
    Ophthalmic Res; 1998; 30(6):333-9. PubMed ID: 9731114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy.
    Watanabe D; Suzuma K; Matsui S; Kurimoto M; Kiryu J; Kita M; Suzuma I; Ohashi H; Ojima T; Murakami T; Kobayashi T; Masuda S; Nagao M; Yoshimura N; Takagi H
    N Engl J Med; 2005 Aug; 353(8):782-92. PubMed ID: 16120858
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sustained and expedited resolution of diabetic papillopathy with combined PRP and bevacizumab.
    Chin EK; Almeida DR; Sohn EH
    Can J Ophthalmol; 2015 Oct; 50(5):e88-91. PubMed ID: 26455990
    [No Abstract]   [Full Text] [Related]  

  • 36. Functional and morphological changes in diabetic macular edema over the course of anti-vascular endothelial growth factor treatment.
    Reznicek L; Cserhati S; Seidensticker F; Liegl R; Kampik A; Ulbig M; Neubauer AS; Kernt M
    Acta Ophthalmol; 2013 Nov; 91(7):e529-36. PubMed ID: 23647578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of diabetic macular edema in Japan: a review and expert opinion.
    Terasaki H; Ogura Y; Kitano S; Sakamoto T; Murata T; Hirakata A; Ishibashi T
    Jpn J Ophthalmol; 2018 Jan; 62(1):1-23. PubMed ID: 29210010
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Diabetic retinopathy].
    Fukushima H; Kato S
    Nihon Rinsho; 2015 Dec; 73(12):2032-6. PubMed ID: 26666149
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravitreal bevacizumab versus panretinal photocoagulation for treatment-naïve proliferative and severe nonproliferative diabetic retinopathy.
    Ernst BJ; García-Aguirre G; Oliver SC; Olson JL; Mandava N; Quiroz-Mercado H
    Acta Ophthalmol; 2012 Nov; 90(7):e573-4. PubMed ID: 22405048
    [No Abstract]   [Full Text] [Related]  

  • 40. Vascular endothelial growth factor plays a role in hyperpermeability of diabetic retinal vessels.
    Murata T; Ishibashi T; Khalil A; Hata Y; Yoshikawa H; Inomata H
    Ophthalmic Res; 1995; 27(1):48-52. PubMed ID: 7596559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.